|
|
Therapy-related myeloid neoplasms following treatment with PARP inhibitors: new molecular insights
J.E. Martin
,
S. Khalife-Hachem
,
T. Grinda
,
M. Kfoury
,
S. Garciaz
et al.
Journal articles
hal-03623367v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
17q21.31 duplication causes prominent tau-related dementia with increased MAPT expression
K. Le Guennec
,
O. Quenez
,
G. Nicolas
,
D. Wallon
,
S. Rousseau
et al.
Journal articles
hal-01832142v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Facteurs associés à la survie et l'entrée en institution des patients déments suivis en consultation mémoire.
J.P. Marissal
,
F. Pasquier
Revue Neurologique, 2005, 161 (12-C2), pp.71-72
Journal articles
hal-00200170v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Incremental value of 18F-florbetaben amyloid PET in the diagnostic work-up of most complex patients with dementia in France: a naturalistic study
E. Guedj
,
T. Jonveaux
,
A. Verger
,
P. Krolak-Salmon
,
C. Houzard
et al.
European Journal of Nuclear Medicine and Molecular Imaging, 2017, 44 (2), pp.S169
Journal articles
hal-03606879v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Therapy-related myeloid neoplasms following treatment with PARP inhibitors: new molecular insights
J.E. Martin
,
S. Khalife-Hachem
,
T. Grinda
,
M. Kfoury
,
S. Garciaz
et al.
Journal articles
hal-03376715v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|